Comment on: residual viraemia does not influence 1 year virological rebound in HIV-infected patients with HIV RNA persistently below 50 copies/mL.
نویسندگان
چکیده
349, p. 198. Foundation for Retrovirology and Human Health, Alexandria, VA, USA. 3 Doyle T, Smith C, Vitiello P et al. Plasma HIV-1 detection below 50 copies/mL and risk of virologic rebound in patients receiving highly active antiretroviral therapy. Clin Infect Dis 2012; 54:
منابع مشابه
Residual viraemia does not influence 1 year virological rebound in HIV-infected patients with HIV RNA persistently below 50 copies/mL.
OBJECTIVES It is currently debated whether patients with residual viraemia are at higher risk of virological failure than those attaining <1 HIV RNA copy/mL. We therefore investigated the effect of residual viraemia on virological rebound. METHODS We used a prospective, non-interventional, single-centre, study. This analysis was based on HIV-infected patients with two consecutive HIV RNA vira...
متن کاملPredictors of residual viraemia in patients on long-term suppressive antiretroviral therapy.
BACKGROUND HIV-1-infected individuals with plasma RNA<50 copies/ml on antiretroviral therapy (ART) may have residual, low-level viraemia detectable by PCR assays that are able to detect a single copy of viral RNA (single-copy assay [SCA]). The clinical predictors of residual viraemia in patients on long-term suppressive ART are not yet fully understood. METHODS We evaluated factors associated...
متن کاملAny impact of blips and low-level viraemia episodes among HIV-infected patients with sustained virological suppression on ART?
OBJECTIVES The objective of this study was to evaluate the prevalence of blips and risk of virological failure (VF) among HIV-infected patients with sustained virological suppression (HIV-RNA <50 copies/mL) on ART. METHODS Newly diagnosed (2004-13) HIV-infected patients with sustained virological suppression on ART (minimum follow-up of 3 months) were identified. Risk of VF was evaluated acco...
متن کاملLow level viraemia and the risk of virological failure in HIV infected patients
Objective: to estimate the rate and the significance of low level viraemia in HIV positive patients registered in the National Institute for Infectious Diseases “Prof. Dr. Matei Balş”, Bucharest, Romania. We retrospectively analysed the rate of HIV viral loads (VL) <200 copies/mL in patients admitted in our institute from 2011 to 2013. The patients with undetectable VLs in 2011 and low level VL...
متن کاملImpact of pre-therapy viral load on virological response to modern first-line HAART.
BACKGROUND We tested whether pre-HAART viraemia affects the achievement and maintenance of virological success in HIV-1-infected patients starting modern first-line therapies. METHODS A total of 1,430 patients starting their first HAART (genotype-tailored) in 2008 (median; IQR: 2006-2009) were grouped according to levels of pre-HAART viraemia (≤ 30,000, 30,001-100,000, 100,001-300,000, 300,00...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- The Journal of antimicrobial chemotherapy
دوره 67 10 شماره
صفحات -
تاریخ انتشار 2012